ClinicalTrials.gg
CompletedNCT06187467Updated Oct 7, 2026

Longitudinal Multimodal Profiling of Balance and Gait In Stroke

An observational study in Stroke, sponsored by Tan Tock Seng Hospital. Completed at 1 site in Singapore. Open to participants aged 21 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Tan Tock Seng Hospital · Observational

How we know

Updated Oct 7, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
16
Ages
21 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Stroke by Tan Tock Seng Hospital — 3 open to participants now, 6 under way, none of them phase 3. Stroke · Tan Tock Seng Hospital.

Started
2024
with 6 others
Observational
9 of 29
1 open now
Registered
21st of 29
by date

Among the 29 studies in Stroke by Tan Tock Seng Hospital, this one is one of 7 that started in 2024, is one of 9 observational ones, and was the 21st registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

3 of the 29 studies in Stroke by Tan Tock Seng Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 21 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Stroke by Tan Tock Seng Hospital, or all of them as a file.
02

Study summary

Balance and gait recovery is a critical aspect of post-stroke motor rehabilitation. Researchers have effectively utilized EEG to investigate different aspects of lower limb motor control, however there are several technical challenges in the existing brain computer interface (BCI) motor profiling.

The study aims to test the EEG-BCI system to see if it's effective in understanding the balance and walking patterns of post-stroke populations.

Read the detailed description

Brain Computer Interface represent a groundbreaking field at the crossroads of neuroscience and engineering, serving as a direct communication link between the human brain and computer system.

Despite advancements in BCI technology, the electrocortical oscillations during human walking remain relatively unexplored, providing an opportunity for pioneering investigations.

The research highlights the feasibility of using EEG to decode neural patterns associated with various functions and aims to contribute to existing knowledge by using advanced EEG-based techniques to predict balance and gait patterns with the ultimate goal of tailoring rehabilitation approaches to individual patient needs.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Electroencephalographic (EEG)
  • Brain Computer Interfaces
04

Who can participate

Ages eligible
21 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients in outpatient clinics

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • First-ever clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors brain imaging
  • Age 21 to 85 years
  • At least ≥ 30 days post-stroke
  • Gait impairments related to stroke
  • Functional ambulation category -6 levels (Mehrholz et al, 2007): FAC ≥ 4, i.e. able to ambulate independently on level surface but requires supervision to negotiate (e.g. stairs, inclines, non-level surfaces).
  • (MoCA) score > 21 (Nasreddine et al., 2005)
  • Able to understand study instructions and requirements

Exclusion criteria

Exclusion Criteria:

  • Non-stroke related causes of gait impairment
  • Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease, congestive heart failure, bronchial asthma, severe /untreated depression, agitation, end stage renal/liver/heart/lung failure, dialysis, unresolved cancers e.g.,), active seizures within 3 months
  • Anticipated of \< 6 months
  • On subcutaneous or oral anti-coagulation
  • Local factors potentially worsened by gait training: joint and muscle pains
  • Lower limb pain VAS >4/10, active lower limb fractures or arthritis, fixed leg contractures, severe peripheral vascular disease, organomegaly or aortic aneurysms
  • Active unhealed skin wounds or inflammatory skin conditions over trunk and lower limbs,
  • Severe visual impairment or visual neglect affecting navigation
  • Known allergy to EEG gel (Recoverix)
  • Presence of craniectomy skull defect
  • Resident of nursing home or overseas country which may compromise attendance at research site
  • Pregnant or lactating females
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
16 participants (actual)
Patient registry
No

Interventions

  • OtherClinical and technological-aided assessments and questionnaires

    Assessments and questionnaires to quantify cortical and motor activities using portable EEG and lower limb sensors during dynamic balance and gait activities.

06

What researchers measure

Primary outcomes

  1. EEG Activities

    To record EEG and EOG data from 64-Ch ActiCap EEG cap and electrode

    Time frame: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  2. Goniometers

    7 sensors to measure 2-axis joint angles at bilateral Hip, Knee and Ankle

    Time frame: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

Secondary outcomes

  1. Fugl Meyer Assessment for Lower Limbs

    Change in Fugl Meyer Motor Assessment score in the affected arm, minimum: 0, maximum: 66 with higher scores indicating greater levels of mobility function

    Time frame: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  2. Berg Balance Scale

    To assess functional balance

    Time frame: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  3. Modified Clinical Test for Sensory Interaction in Balance

    Assess complex sensory system to assist in determining which sensory system the individual relies upon (visual, somatosensory, vestibul)

    Time frame: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  4. 10-metre Walk Test

    To assess walking speed over a short distance

    Time frame: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  5. 6-minute Walk Test

    Determine the functional exercise capacity

    Time frame: Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

07

Study locations

1 site
  • Tan Tock Seng Hospital
    Singapore, Singapore, Singapore
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Jun 2025, 11 months.

Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's 11 months is below that.

Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: primary completion Oct 2025 → Jun 2025 and completion Oct 2025 → Jun 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 4, 2023
First posted
Jan 2, 2024
StartActual
Jul 1, 2024
Primary completionActual
Jun 20, 2025was Oct 2025
CompletionActual
Jun 20, 2025was Oct 2025
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 7, 2026
Sites
1 site added, 1 site removed
Show site
  • Tan Tock Seng Hospital · Singapore, Singapore
Show 1 removed
  • Tan Tock Seng Hospital · Singapore, Singapore
Oct 7, 2026
Primary completion
Oct 2025→Jun 20, 2025 (actual)
Oct 7, 2026
Study completion
Oct 2025→Jun 20, 2025 (actual)
Oct 7, 2026
Enrollment
30 (estimated)→16 (actual)
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Recruiting→Completed
    1 site added, 1 site removed
    Show site
    • Tan Tock Seng Hospital · Singapore, Singapore
    Show 1 removed
    • Tan Tock Seng Hospital · Singapore, Singapore
    Primary completion Oct 2025→Jun 20, 2025 (now actual)
    Study completion Oct 2025→Jun 20, 2025 (now actual)
    Enrollment 30 (estimated)→16 (actual)
    + 4 other changes: verification date, oversight details, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06187467
Collaborators
Nanyang Technological University
Responsible party
Sponsor
First posted
Jan 2, 2024
Start date
Jul 1, 2024
Primary completion
Jun 20, 2025
Completion
Jun 20, 2025
Last update
Oct 7, 2026

Study contacts

Dr Wee Seng Kwee
principal investigator · Tan Tock Seng Hospital
Dr Karen Chua
principal investigator · Tan Tock Seng Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion